Pubblicazioni

IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET)

2022 - TRIALS

Nochi, Z.; Pia, H.; Bloms-Funke, P.; Boesl, I.; Caspani, O.; Chapman, S. C.; Fardo, F.; Genser, B.; Goetz, M.; Kostenko, A. V.; Leone, C.; Li, T.; Mouraux, A.; Pelz, B.; Pogatzki-Zahn, E.; Schilder, A.; Schnetter, E.; Schubart, K.; Stouffs, A.; Tracey, I.; Troconiz, I. F.; Truini, A.; Van Niel, J.; Vela, J. M.; Vincent, K.; Vollert, J.; Wanigasekera, V.; Wittayer, M.; Tankisi, H.; Finnerup, N. B.; Phillips, K. G.; Treede, R. -D.